Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 201

1.

Credibility-enhancing displays promote the provision of non-normative public goods.

Kraft-Todd GT, Bollinger B, Gillingham K, Lamp S, Rand DG.

Nature. 2018 Nov;563(7730):245-248. doi: 10.1038/s41586-018-0647-4. Epub 2018 Oct 24.

PMID:
30356217
2.

Uncertainty in forecasts of long-run economic growth.

Christensen P, Gillingham K, Nordhaus W.

Proc Natl Acad Sci U S A. 2018 May 22;115(21):5409-5414. doi: 10.1073/pnas.1713628115. Epub 2018 May 14.

3.

Lessons from first campus carbon-pricing scheme.

Gillingham K, Carattini S, Esty D.

Nature. 2017 Oct 31;551(7678):27-29. doi: 10.1038/551027a. No abstract available.

PMID:
29094718
4.

Rapid Discontinuation of Prednisone in Kidney Transplant Recipients: 15-Year Outcomes From the University of Minnesota.

Serrano OK, Kandaswamy R, Gillingham K, Chinnakotla S, Dunn TB, Finger E, Payne W, Ibrahim H, Kukla A, Spong R, Issa N, Pruett TL, Matas A.

Transplantation. 2017 Oct;101(10):2590-2598. doi: 10.1097/TP.0000000000001756.

5.

Reforming the U.S. coal leasing program.

Gillingham K, Bushnell J, Fowlie M, Greenstone M, Kolstad C, Krupnick A, Morris A, Schmalensee R, Stock J.

Science. 2016 Dec 2;354(6316):1096-1098. No abstract available.

PMID:
27934718
6.

Post-transplant blood transfusions and pediatric renal allograft outcomes.

Verghese P, Gillingham K, Matas A, Chinnakotla S, Chavers B.

Pediatr Transplant. 2016 Nov;20(7):939-945. doi: 10.1111/petr.12788. Epub 2016 Oct 6.

7.

Return to normal activities and work after living donor laparoscopic nephrectomy.

Larson DB, Jacobs C, Berglund D, Wiseman J, Garvey C, Gillingham K, Ibrahim HN, Matas AJ.

Clin Transplant. 2017 Jan;31(1). doi: 10.1111/ctr.12862. Epub 2016 Dec 22.

PMID:
27740731
8.

CLIMATE ECONOMICS. Opportunities for advances in climate change economics.

Burke M, Craxton M, Kolstad CD, Onda C, Allcott H, Baker E, Barrage L, Carson R, Gillingham K, Graff-Zivin J, Greenstone M, Hallegatte S, Hanemann WM, Heal G, Hsiang S, Jones B, Kelly DL, Kopp R, Kotchen M, Mendelsohn R, Meng K, Metcalf G, Moreno-Cruz J, Pindyck R, Rose S, Rudik I, Stock J, Tol RS.

Science. 2016 Apr 15;352(6283):292-3. doi: 10.1126/science.aad9634. Epub 2016 Apr 14. No abstract available.

PMID:
27081055
9.

Environmental Economics. Using and improving the social cost of carbon.

Pizer W, Adler M, Aldy J, Anthoff D, Cropper M, Gillingham K, Greenstone M, Murray B, Newell R, Richels R, Rowell A, Waldhoff S, Wiener J.

Science. 2014 Dec 5;346(6214):1189-90. doi: 10.1126/science.1259774. No abstract available.

PMID:
25477446
10.

Calcineurin inhibitors in HLA-identical living related donor kidney transplantation.

Verghese PS, Dunn TB, Chinnakotla S, Gillingham KJ, Matas AJ, Mauer MS.

Nephrol Dial Transplant. 2014 Jan;29(1):209-18. doi: 10.1093/ndt/gft447. Review.

11.

Antihypertensive pharmacotherapy and long-term outcomes in pediatric kidney transplantation.

Suszynski TM, Rizzari MD, Gillingham KJ, Rheault MN, Kraszkiewicz W, Matas AJ, Chavers BM.

Clin Transplant. 2013 May-Jun;27(3):472-80. doi: 10.1111/ctr.12125. Epub 2013 May 6.

12.

Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation.

Suszynski TM, Gillingham KJ, Rizzari MD, Dunn TB, Payne WD, Chinnakotla S, Finger EB, Sutherland DER, Najarian JS, Pruett TL, Matas AJ, Kandaswamy R.

Am J Transplant. 2013 Apr;13(4):961-970. doi: 10.1111/ajt.12166. Epub 2013 Feb 22.

13.

Long-term shifts in life-cycle energy efficiency and carbon intensity.

Yeh S, Mishra GS, Morrison G, Teter J, Quiceno R, Gillingham K, Riera-Palou X.

Environ Sci Technol. 2013 Mar 19;47(6):2494-501. doi: 10.1021/es3029268. Epub 2013 Mar 1.

PMID:
23409918
14.

Energy policy: The rebound effect is overplayed.

Gillingham K, Kotchen MJ, Rapson DS, Wagner G.

Nature. 2013 Jan 24;493(7433):475-6. doi: 10.1038/493475a. No abstract available.

PMID:
23344343
15.

Graft loss due to recurrent disease in pediatric kidney transplant recipients on a rapid prednisone discontinuation protocol.

Chavers BM, Rheault MN, Gillingham KJ, Matas AJ.

Pediatr Transplant. 2012 Nov;16(7):704-10. doi: 10.1111/j.1399-3046.2012.01714.x. Epub 2012 May 11.

16.

Ten-year outcome after rapid discontinuation of prednisone in adult primary kidney transplantation.

Rizzari MD, Suszynski TM, Gillingham KJ, Dunn TB, Ibrahim HN, Payne WD, Chinnakotla S, Finger EB, Sutherland DE, Kandaswamy R, Najarian JS, Pruett TL, Kukla A, Spong R, Matas AJ.

Clin J Am Soc Nephrol. 2012 Mar;7(3):494-503. doi: 10.2215/CJN.08630811. Epub 2012 Jan 26.

17.

Outcome of living kidney donors left with multiple renal arteries.

Rizzari MD, Suszynski TM, Gillingham KJ, Matas AJ, Ibrahim HN.

Clin Transplant. 2012 Jan-Feb;26(1):E7-11. doi: 10.1111/j.1399-0012.2011.01548.x. Epub 2011 Oct 23.

18.

Revisiting traditional risk factors for rejection and graft loss after kidney transplantation.

Dunn TB, Noreen H, Gillingham K, Maurer D, Ozturk OG, Pruett TL, Bray RA, Gebel HM, Matas AJ.

Am J Transplant. 2011 Oct;11(10):2132-43. doi: 10.1111/j.1600-6143.2011.03640.x. Epub 2011 Aug 3.

19.

In vitro biocompatibility of modified potassium fluorrichterite and potassium fluorrichterite-fluorapatite glass-ceramics.

Bhakta S, Gillingham KH, Mirsaneh M, Miller CA, Reaney IM, Brook IM, van Noort R, Hatton PV.

J Mater Sci Mater Med. 2011 Sep;22(9):2065-70. doi: 10.1007/s10856-011-4382-8. Epub 2011 Jun 25.

PMID:
21706217
20.

Consideration of donor age and human leukocyte antigen matching in the setting of multiple potential living kidney donors.

Rizzari MD, Suszynski TM, Gillingham KJ, Matas AJ.

Transplantation. 2011 Jul 15;92(1):70-5. doi: 10.1097/TP.0b013e31821cded7.

21.

Recurrent glomerulonephritis under rapid discontinuation of steroids.

Kukla A, Chen E, Spong R, Weber M, El-Shahawi Y, Gillingham K, Matas AJ, Ibrahim HN.

Transplantation. 2011 Jun 27;91(12):1386-91. doi: 10.1097/TP.0b013e31821bf157.

22.

Carbon accounting a tricky business.

Friedland AJ, Gillingham KT.

Science. 2010 Jan 22;327(5964):411-2. doi: 10.1126/science.327.5964.411. No abstract available.

PMID:
20093457
23.

Diabetes after kidney donation.

Ibrahim HN, Kukla A, Cordner G, Bailey R, Gillingham K, Matas AJ.

Am J Transplant. 2010 Feb;10(2):331-7. doi: 10.1111/j.1600-6143.2009.02944.x. Epub 2009 Dec 23.

24.

Pediatric kidney transplantation using a novel protocol of rapid (6-day) discontinuation of prednisone: 2-year results.

Chavers BM, Chang YC, Gillingham KJ, Matas A.

Transplantation. 2009 Jul 27;88(2):237-41. doi: 10.1097/TP.0b013e3181ac6833.

25.

Selective retransplant after graft loss to nonadherence: success with a second chance.

Dunn TB, Browne BJ, Gillingham KJ, Kandaswamy R, Humar A, Payne WD, Sutherland DE, Matas AJ.

Am J Transplant. 2009 Jun;9(6):1337-46. doi: 10.1111/j.1600-6143.2009.02625.x. Epub 2009 May 13.

26.

Pregnancy outcomes after kidney donation.

Ibrahim HN, Akkina SK, Leister E, Gillingham K, Cordner G, Guo H, Bailey R, Rogers T, Matas AJ.

Am J Transplant. 2009 Apr;9(4):825-34.

27.

Kidney transplant half-life (t[1/2]) after rapid discontinuation of prednisone.

Matas AJ, Gillingham K, Kandaswamy R, Dunn TB, Payne WD, Sutherland DE, Humar A.

Transplantation. 2009 Jan 15;87(1):100-2. doi: 10.1097/TP.0b013e31818c25ab.

28.

2202 kidney transplant recipients with 10 years of graft function: what happens next?

Matas AJ, Gillingham KJ, Humar A, Kandaswamy R, Sutherland DE, Payne WD, Dunn TB, Najarian JS.

Am J Transplant. 2008 Nov;8(11):2410-9. doi: 10.1111/j.1600-6143.2008.02414.x.

29.

Posttransplant diabetes mellitus and acute rejection: impact on kidney transplant outcome.

Matas AJ, Gillingham KJ, Humar A, Ibrahim HN, Payne WD, Gruessner RW, Dunn TB, Sutherland DE, Najarian JS, Kandaswamy R.

Transplantation. 2008 Feb 15;85(3):338-43. doi: 10.1097/TP.0b013e318160ee42.

PMID:
18301329
30.

Increased urologic complications in children after kidney transplants for obstructive and reflux uropathy.

Khositseth S, Askiti V, Nevins TE, Matas AJ, Ingulli EG, Najarian JS, Gillingham KJ, Chavers BM.

Am J Transplant. 2007 Sep;7(9):2152-7.

31.
32.

Stable kidney function in the second decade after kidney transplantation while on cyclosporine-based immunosuppression.

Kandaswamy R, Humar A, Casingal V, Gillingham KJ, Ibrahim H, Matas AJ.

Transplantation. 2007 Mar 27;83(6):722-6.

PMID:
17414704
33.

Risk factors for rising creatinine in renal allografts with 1 and 3 yr survival.

Paraskevas S, Kandaswamy R, Humar A, Gillingham KJ, Gruessner RW, Payne WD, Najarian JS, Sutherland DE, Matas AJ.

Clin Transplant. 2006 Nov-Dec;20(6):667-72.

PMID:
17100713
34.

Graft loss from recurrent glomerulonephritis is not increased with a rapid steroid discontinuation protocol.

Ibrahim H, Rogers T, Casingal V, Sturdevant M, Tan M, Humar A, Gillingham K, Matas A.

Transplantation. 2006 Jan 27;81(2):214-9.

PMID:
16436965
35.

Prednisone-free maintenance immunosuppression-a 5-year experience.

Matas AJ, Kandaswamy R, Gillingham KJ, McHugh L, Ibrahim H, Kasiske B, Humar A.

Am J Transplant. 2005 Oct;5(10):2473-8.

36.

A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients--an interim analysis.

Kandaswamy R, Melancon JK, Dunn T, Tan M, Casingal V, Humar A, Payne WD, Gruessner RW, Dunn DL, Najarian JS, Sutherland DE, Gillingham KJ, Matas AJ.

Am J Transplant. 2005 Jun;5(6):1529-36.

37.

Thymoglobulin versus ATGAM induction therapy in pediatric kidney transplant recipients: a single-center report.

Khositseth S, Matas A, Cook ME, Gillingham KJ, Chavers BM.

Transplantation. 2005 Apr 27;79(8):958-63.

PMID:
15849550
38.

Mycobacterial infections after kidney transplant.

Jie T, Matas AJ, Gillingham KJ, Sutherland DE, Dunn DL, Humar A.

Transplant Proc. 2005 Mar;37(2):937-9.

PMID:
15848580
39.

Rapid discontinuation of prednisone in higher-risk kidney transplant recipients.

Khwaja K, Asolati M, Harmon JV, Melancon JK, Dunn TB, Gillingham KJ, Kandaswamy R, Humar A, Gruessner RW, Payne WD, Najarian JS, Dunn DL, Sutherland DE, Matas AJ.

Transplantation. 2004 Nov 15;78(9):1397-9.

PMID:
15548981
40.

Urolithiasis after kidney transplantation in pediatric recipients: a single center report.

Khositseth S, Gillingham KJ, Cook ME, Chavers BM.

Transplantation. 2004 Nov 15;78(9):1319-23.

PMID:
15548970
41.

Long-term immunosuppression, without maintenance prednisone, after kidney transplantation.

Matas AJ, Kandaswamy R, Humar A, Payne WD, Dunn DL, Najarian JS, Gruessner RW, Gillingham KJ, McHugh LE, Sutherland DE.

Ann Surg. 2004 Sep;240(3):510-6; discussion 516-7.

42.

Outcome at 3 years with a prednisone-free maintenance regimen: a single-center experience with 349 kidney transplant recipients.

Khwaja K, Asolati M, Harmon J, Melancon JK, Dunn T, Gillingham K, Kandaswamy R, Humar A, Gruessner R, Payne W, Najarian J, Dunn D, Sutherland D, Matas AJ.

Am J Transplant. 2004 Jun;4(6):980-7.

43.

Predicting long-term kidney graft survival: can new trials be performed?

Paraskevas S, Kandaswamy R, Humar A, Gillingham K, Gruessner RW, Payne WD, Najarian JS, Dunn DL, Sutherland DE, Matas AJ.

Transplantation. 2003 Apr 27;75(8):1256-9.

PMID:
12717212
44.

Hyperlipidemia in pediatric kidney transplant recipients treated with cyclosporine.

Chavers BM, Hårdstedt M, Gillingham KJ.

Pediatr Nephrol. 2003 Jun;18(6):565-9. Epub 2003 Apr 24.

PMID:
12712377
45.

Positive remote crossmatch: impact on short-term and long-term outcome in cadaver renal transplantation.

Noreen HJ, McKinley DM, Gillingham KJ, Matas AJ, Segall M.

Transplantation. 2003 Feb 27;75(4):501-5.

PMID:
12605118
46.

Improved late graft survival and half-lives in pediatric kidney transplantation: a single center experience.

Vats A, Gillingham K, Matas A, Chavers B.

Am J Transplant. 2002 Nov;2(10):939-45.

47.

Osteonecrosis of the femoral head after solid organ transplantation: a prospective study.

Marston SB, Gillingham K, Bailey RF, Cheng EY.

J Bone Joint Surg Am. 2002 Dec;84-A(12):2145-51.

PMID:
12473701
48.

Risk factors for slow graft function after kidney transplants: a multivariate analysis.

Humar A, Ramcharan T, Kandaswamy R, Gillingham K, Payne WD, Matas AJ.

Clin Transplant. 2002 Dec;16(6):425-9.

PMID:
12437622
49.

Five preventable causes of kidney graft loss in the 1990s: a single-center analysis.

Matas AJ, Humar A, Gillingham KJ, Payne WD, Gruessner RW, Kandaswamy R, Dunn DL, Najarian JS, Sutherland DE.

Kidney Int. 2002 Aug;62(2):704-14.

50.

Rapid discontinuation of steroids in living donor kidney transplantation: a pilot study.

Matas AJ, Ramcharan T, Paraskevas S, Gillingham KJ, Dunn DL, Gruessner RW, Humar A, Kandaswamy R, Najarian JS, Payne WD, Sutherland DE.

Am J Transplant. 2001 Sep;1(3):278-83.

Supplemental Content

Loading ...
Support Center